Evidence map›Paper›PMID 33025551›Full record

ArticleJournal of endocrinological investigation2021

Identification of four novel variant in the AMHR2 gene in six unrelated Turkish families.

E Unal, A A Karakaya, A Beştaş, R Yıldırım, F F Taş, H Onay, F Özkınay, Y K Haspolat

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Identification ofGenes · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

E UnalDepartment of Pediatric Endocrinology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey. edip76@yahoo.com.ORCID http://orcid.org/0000-0002-9809-0977
A A KarakayaDepartment of Pediatric Endocrinology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey.ORCID http://orcid.org/0000-0001-7004-6803
A BeştaşDepartment of Pediatric Endocrinology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey.ORCID http://orcid.org/0000-0003-3289-6887
R YıldırımDepartment of Pediatric Endocrinology, Diyarbakır Children's Hospital, Diyarbakir, Turkey.ORCID http://orcid.org/0000-0002-9558-3856
F F TaşDepartment of Pediatric Endocrinology, Gazi Yaşargil Training and Research Hospital, Diyarbakir, Turkey.ORCID http://orcid.org/0000-0003-2438-0602
H OnayDepartment of Medical Genetics, Faculty of Medicine, Ege University, Izmir, Turkey.ORCID http://orcid.org/0000-0002-0584-8866
F ÖzkınayDepartment of Medical Genetics, Faculty of Medicine, Ege University, Izmir, Turkey.ORCID http://orcid.org/0000-0001-7542-7787
Y K HaspolatDepartment of Pediatric Endocrinology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey.ORCID http://orcid.org/0000-0003-1930-9721

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePersistent Müllerian duct syndrome (PMDS) is characterized by the persistence of Müllerian structures in male with normal phenotype. Most cases occur as a result of mutations in the anti-Müllerian hormone (AMH) or AMHR2 genes. In this study, we aim to discuss the results of clinical, laboratory, and molecular genetic analysis of cases detected to have AMHR2 gene mutation.

methodsA total of 11 cases from 6 families were included in the study. AMHR2 gene mutation analyses were performed by sequencing of the coding exons and the exon-intron boundaries of the genes. The American College of Medical Genetics guidelines were used for the classification of the detected variants.

resultsSix of the 11 cases were admitted due to bilateral undescended testes and five cases due to inguinal hernia (three transverse testicular ectopia and two hernia uterus inguinalis). All cases had normal AMH levels. Seven different variants were identified in the six families. The variants detected in four cases were considered novel (c.78del, c.71G > A, c.1460dup, c.1319A > G). Two of the novel variants were missense (exon 2 and exon 10) mutations, one was deletion (exon 2), and one duplication (exon 11).

conclusionWe identified four novel mutations in the AMHR2 gene resulting in PMDS. Duplication mutation (c.1460dup) in the AMHR2 gene causing PMDS was demonstrated for the first time. The most important complications of PMDS are infertility and malignancy. Early diagnosis is vital to preventing malignancy. Vas deferens and vascular structures may be injured during orchiopexy. Therefore, patients should always be referred to experienced clinics.

Indexed as

Disorder of Sex Development, 46,XYAnti-Mullerian HormoneChild, PreschoolConsanguinityEarly DiagnosisHumansInfertility, MaleMaleMutationNeoplasmsPedigreeReceptors, PeptideReceptors, Transforming Growth Factor betaTurkeyAnti-Mullerian Hormoneanti-Mullerian hormone receptorReceptors, PeptideReceptors, Transforming Growth Factor betaAMHR2Novel mutationPersistent Müllerian duct syndromeUndescended testes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.